WUHAN XIMO · LiZhiZhu

Quality medicines.For bone health.

MEDICINE INFORMATION

LiZhiZhu Compound Calcium Carbonate Granules — Medicine Information

Product identity, indications, directions and safety information.

Product identity

Medicine information · Product identity
Brand / generic nameLiZhiZhu / Compound Calcium Carbonate Granules
China drug approvalChina Drug Approval No. H20173214
Manufacturer / MAHWuhan Ximo Pharmaceutical Co., Ltd.
Prescription statusPrescription medicine in China
IngredientsThe finished product is a compound preparation, consisting of 0.75 grams of calcium carbonate (equivalent to 0.3 grams of calcium) per bag and 62.5 units of vitamin D3
Strength3.4g: 0.75g of calcium carbonate and 62.5IU of vitamin D3
AppearanceWhite and off-white granules

Indications

Medicine information · Indications
IndicationsPrevention and treatment of calcium deficiency. Such as osteoporosis, hand and foot convulsions, bone dysplasia, rickets, as well as calcium supplementation for pregnant and lactating women and menopausal women.

Preparation and dose

Medicine information · Preparation and dose
Preparation and dosePour the granules from the sachet into a teacup, add 50–60 mL of cool boiled water, and take orally immediately after the bubbles disappear (about 5–8 minutes). Supplement as appropriate according to individual needs and dietary calcium intake. Daily dose: 500–1000 mg (calculated as calcium). Adults: 1 sachet 2–3 times daily; children: 1 sachet 1–2 times daily, or as directed by a physician.

Safety information

Medicine information · Safety information
Adverse reactionsBelching and constipation; milk-alkali syndrome may occasionally occur, presenting as hypercalcaemia, alkalosis and renal impairment.
ContraindicationsAllergy to this product; hypercalcaemia, hypercalciuria, vitamin D excess, hyperphosphataemic renal rickets; use during digitalis treatment.
Precautions
  1. Use with caution in patients with renal impairment.
  2. Use with caution in patients with arteriosclerosis, cardiac insufficiency, hypercholesterolaemia, hyperphosphataemia or hypersensitivity to vitamin D.
  3. Do not take this medicine if its appearance has changed.
  4. Children must use this medicine under adult supervision.
  5. Keep this medicine out of the reach of children.
Interaction information
  1. Heavy consumption of alcoholic or caffeinated drinks and heavy smoking can inhibit calcium absorption.
  2. Eating large amounts of fibre-rich foods can inhibit calcium absorption because calcium binds to fibre to form compounds that are not readily absorbed.
  3. When used with phenytoin or tetracyclines, absorption of both is reduced.
  4. Contraceptives and oestrogens can increase calcium absorption.
  5. When aluminium-containing antacids are taken with this medicine, aluminium absorption increases.
  6. When used with calcium channel blockers (such as nifedipine), blood calcium may rise significantly above normal, while the effects of medicines such as verapamil hydrochloride are reduced.
  7. Combined use with thiazide diuretics increases renal tubular calcium reabsorption and may lead to hypercalcaemia.
  8. Do not use in combination with digitalis medicines.
  9. Watch for cardiac arrhythmias when used with potassium-containing medicines.
  10. If you are taking other medicines, consult a physician or pharmacist before using this medicine.

Storage and other information

Medicine information · Storage and other information
Storage遮光,密封、25℃以下、干燥处保存。
Shelf life24 months
Quality standardYBH01802017
Label revision2022-03-04
← Back to product overview
Ximo information image

Creating high-quality medicines to safeguard bone health

ONLINE PURCHASE

Online Purchase

Select a platform to search for product information. These links are platform search pages.

JD.comJD.comSearch on platform ↗TaobaoTaobaoSearch on platform ↗TmallTmallSearch on platform ↗PinduoduoPinduoduoSearch on platform ↗

Prescription medicine. Purchase with a physician’s prescription and use under the guidance of a physician or pharmacist.